Retrovirus from the HIV group and its use (MVP-2901/94)

Details Retrovirus from the HIV group and its use (MVP-2901/94) Retrovirus from the HIV group and its use (MVP-2901/94)

1997-12-12

2000-12-19

Stucker, Jeffrey

Chemistry: molecular biology and microbiology

Virus or bacteriophage, except for viral vector or...

439974, G09B 1900

Patent

active

061626317

ABSTRACT:
A novel immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 95012601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.

REFERENCES:
patent: 2107732 (1938-10-01), Gurtler et al.
patent: 5759770 (1998-06-01), Guertler et al.
patent: 5798205 (1998-08-01), Hauser et al.
Vanden Haesevelde et al., "Genomic Cloning and Complete Sequence Analysis of a Highly Divergent African Human Immunodeficiency Virus Isolate," Journal of Virology, 68:3:1586-1596 (1994).
Charneau et al., "Isolated and Envelope Sequence of a Highly Divergent HIV-1 Isolate: Definition of a New HIV-1 Group," Journal of Virology, 205:247-253 (1994).
EMBL Release 42, Cohen et al., Mar. 1995.

Affiliated with

Also associated with

Rating

Retrovirus from the HIV group and its use (MVP-2901/94) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Retrovirus from the HIV group and its use (MVP-2901/94), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retrovirus from the HIV group and its use (MVP-2901/94) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-270317